Melanoma in Solid Organ Transplant Recipients

Area of Science:

• Oncology
• Transplant Surgery
• Dermatology

Background:

• Solid organ transplant recipients (SOTRs) have a higher risk of developing melanoma compared to immunocompetent individuals.
• Melanoma in SOTRs presents unique challenges due to immunosuppression and higher mortality rates.
• Three distinct clinical scenarios exist: pre-existing melanoma, de novo melanoma, and donor-derived melanoma.

Purpose of the Study:

• To review the clinical scenarios of melanoma development in solid organ transplant recipients.
• To identify key factors for managing melanoma risk in transplant candidates.
• To highlight the importance of screening for donor-derived melanoma.

Main Methods:

• Literature review of clinical scenarios involving melanoma in solid organ transplant recipients.
• Analysis of risk factors, diagnostic challenges, and treatment implications.
• Evaluation of preventive strategies, including donor screening.

Main Results:

• SOTRs have a significantly elevated risk of melanoma with higher mortality, particularly in advanced stages.
• Pre-transplant melanoma management requires careful consideration of tumor stage, residual disease, and time to transplant.
• Donor-derived melanoma, though rare, carries a very poor prognosis and necessitates thorough clinical history and physical examination for prevention.

Conclusions:

• Melanoma management in SOTRs requires a multidisciplinary approach considering individual risk factors and transplant status.
• Vigilant screening and monitoring are essential to mitigate the increased risk of melanoma in this population.
• Preventing donor-to-recipient melanoma transmission is critical, underscoring the importance of donor evaluation.